These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 35490698)

  • 1. Quality standards for the management of non-alcoholic fatty liver disease (NAFLD): consensus recommendations from the British Association for the Study of the Liver and British Society of Gastroenterology NAFLD Special Interest Group.
    McPherson S; Armstrong MJ; Cobbold JF; Corless L; Anstee QM; Aspinall RJ; Barclay ST; Brennan PN; Cacciottolo TM; Goldin RD; Hallsworth K; Hebditch V; Jack K; Jarvis H; Johnson J; Li W; Mansour D; McCallum M; Mukhopadhya A; Parker R; Ross V; Rowe IA; Srivastava A; Thiagarajan P; Thompson AI; Tomlinson J; Tsochatzis EA; Yeoman A; Alazawi W
    Lancet Gastroenterol Hepatol; 2022 Aug; 7(8):755-769. PubMed ID: 35490698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of nonalcoholic fatty liver disease: an evidence-based clinical practice review.
    Arab JP; Candia R; Zapata R; Muñoz C; Arancibia JP; Poniachik J; Soza A; Fuster F; Brahm J; Sanhueza E; Contreras J; Cuellar MC; Arrese M; Riquelme A
    World J Gastroenterol; 2014 Sep; 20(34):12182-201. PubMed ID: 25232252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advancing the global public health agenda for NAFLD: a consensus statement.
    Lazarus JV; Mark HE; Anstee QM; Arab JP; Batterham RL; Castera L; Cortez-Pinto H; Crespo J; Cusi K; Dirac MA; Francque S; George J; Hagström H; Huang TT; Ismail MH; Kautz A; Sarin SK; Loomba R; Miller V; Newsome PN; Ninburg M; Ocama P; Ratziu V; Rinella M; Romero D; Romero-Gómez M; Schattenberg JM; Tsochatzis EA; Valenti L; Wong VW; Yilmaz Y; Younossi ZM; Zelber-Sagi S;
    Nat Rev Gastroenterol Hepatol; 2022 Jan; 19(1):60-78. PubMed ID: 34707258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Malaysian Society of Gastroenterology and Hepatology consensus statement on metabolic dysfunction-associated fatty liver disease.
    Chan WK; Tan SS; Chan SP; Lee YY; Tee HP; Mahadeva S; Goh KL; Ramli AS; Mustapha F; Kosai NR; Raja Ali RA
    J Gastroenterol Hepatol; 2022 May; 37(5):795-811. PubMed ID: 35080048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Canadian Association of Gastroenterology consensus guidelines on safety and quality indicators in endoscopy.
    Armstrong D; Barkun A; Bridges R; Carter R; de Gara C; Dube C; Enns R; Hollingworth R; Macintosh D; Borgaonkar M; Forget S; Leontiadis G; Meddings J; Cotton P; Kuipers EJ;
    Can J Gastroenterol; 2012 Jan; 26(1):17-31. PubMed ID: 22308578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Care Pathway for the Risk Stratification and Management of Patients With Nonalcoholic Fatty Liver Disease.
    Kanwal F; Shubrook JH; Adams LA; Pfotenhauer K; Wai-Sun Wong V; Wright E; Abdelmalek MF; Harrison SA; Loomba R; Mantzoros CS; Bugianesi E; Eckel RH; Kaplan LM; El-Serag HB; Cusi K
    Gastroenterology; 2021 Nov; 161(5):1657-1669. PubMed ID: 34602251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. British Society of Gastroenterology (BSG) and British Society of Paediatric Gastroenterology, Hepatology and Nutrition (BSPGHAN) joint consensus guidelines on the diagnosis and management of eosinophilic oesophagitis in children and adults.
    Dhar A; Haboubi HN; Attwood SE; Auth MKH; Dunn JM; Sweis R; Morris D; Epstein J; Novelli MR; Hunter H; Cordell A; Hall S; Hayat JO; Kapur K; Moore AR; Read C; Sami SS; Turner PJ; Trudgill NJ
    Gut; 2022 Aug; 71(8):1459-1487. PubMed ID: 35606089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults.
    Lamb CA; Kennedy NA; Raine T; Hendy PA; Smith PJ; Limdi JK; Hayee B; Lomer MCE; Parkes GC; Selinger C; Barrett KJ; Davies RJ; Bennett C; Gittens S; Dunlop MG; Faiz O; Fraser A; Garrick V; Johnston PD; Parkes M; Sanderson J; Terry H; ; Gaya DR; Iqbal TH; Taylor SA; Smith M; Brookes M; Hansen R; Hawthorne AB
    Gut; 2019 Dec; 68(Suppl 3):s1-s106. PubMed ID: 31562236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. British Society of Gastroenterology/Association of Coloproctologists of Great Britain and Ireland guidelines for the management of large non-pedunculated colorectal polyps.
    Rutter MD; Chattree A; Barbour JA; Thomas-Gibson S; Bhandari P; Saunders BP; Veitch AM; Anderson J; Rembacken BJ; Loughrey MB; Pullan R; Garrett WV; Lewis G; Dolwani S
    Gut; 2015 Dec; 64(12):1847-73. PubMed ID: 26104751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Criteria for Critical Care Infants and Children: PICU Admission, Discharge, and Triage Practice Statement and Levels of Care Guidance.
    Frankel LR; Hsu BS; Yeh TS; Simone S; Agus MSD; Arca MJ; Coss-Bu JA; Fallat ME; Foland J; Gadepalli S; Gayle MO; Harmon LA; Hill V; Joseph CA; Kessel AD; Kissoon N; Moss M; Mysore MR; Papo ME; Rajzer-Wakeham KL; Rice TB; Rosenberg DL; Wakeham MK; Conway EE;
    Pediatr Crit Care Med; 2019 Sep; 20(9):847-887. PubMed ID: 31483379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AGA Clinical Practice Update: Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Lean Individuals: Expert Review.
    Long MT; Noureddin M; Lim JK
    Gastroenterology; 2022 Sep; 163(3):764-774.e1. PubMed ID: 35842345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The National Consensus statement on the management of adult patients with non-alcoholic fatty liver disease and main comorbidities].
    Maevskaya MV; Kotovskaya YV; Ivashkin VT; Tkacheva ON; Troshina EA; Shestakova MV; Breder VV; Geyvandova NI; Doshchitsin VL; Dudinskaya EN; Ershova EV; Kodzoeva KB; Komshilova KA; Korochanskaya NV; Mayorov AY; Mishina EE; Nadinskaya MY; Nikitin IG; Pogosova NV; Tarzimanova AI; Shamkhalova MS
    Ter Arkh; 2022 Feb; 94(2):216-253. PubMed ID: 36286746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Belgian Association for Study of the Liver Guidance Document on the Management of Adult and Paediatric Non-Alcoholic Fatty Liver Disease.
    Francque S; Lanthier N; Verbeke L; Reynaert H; Van Steenkiste C; Vonghia L; Kwanten WJ; Weyler J; Trépo E; Cassiman D; Smets F; Komuta M; Driessen A; Dirinck E; Danse E; Op de Beeck B; van Craenenbroeck E; Van Nieuwenhove Y; Hubens G; Geerts A; Moreno C
    Acta Gastroenterol Belg; 2018; 81(1):55-81. PubMed ID: 29562379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protocol for a randomised trial testing a community fibrosis assessment service for patients with suspected non-alcoholic fatty liver disease: LOCal assessment and triage evaluation of non-alcoholic fatty liver disease (LOCATE-NAFLD).
    Brain D; O'Beirne J; Hickman IJ; Powell EE; Valery PC; Kularatna S; Tulleners R; Farrington A; Horsfall L; Barnett A
    BMC Health Serv Res; 2020 Apr; 20(1):335. PubMed ID: 32316984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A cross-sectional study of the public health response to non-alcoholic fatty liver disease in Europe.
    Lazarus JV; Ekstedt M; Marchesini G; Mullen J; Novak K; Pericàs JM; Roel E; Romero-Gómez M; Ratziu V; Tacke F; Cortez-Pinto H; Anstee QM;
    J Hepatol; 2020 Jan; 72(1):14-24. PubMed ID: 31518646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paediatric gastroenterology evaluation of overweight and obese children referred from primary care for suspected non-alcoholic fatty liver disease.
    Schwimmer JB; Newton KP; Awai HI; Choi LJ; Garcia MA; Ellis LL; Vanderwall K; Fontanesi J
    Aliment Pharmacol Ther; 2013 Nov; 38(10):1267-77. PubMed ID: 24117728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis and management of non-alcoholic fatty liver disease and related metabolic disorders: consensus statement from the Study Group of Liver and Metabolism, Chinese Society of Endocrinology.
    Gao X; Fan JG;
    J Diabetes; 2013 Dec; 5(4):406-15. PubMed ID: 23560695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recommendations for the detection, diagnosis and follow-up of patients with non-alcoholic fatty liver disease in primary and hospital care.
    Caballeria L; Augustin S; Broquetas T; Morillas RM; Vergara M; Virolés S; Hernández MR; Serra I; Goday A; Vila L; Siso-Almirall A; Solans R; Fernández-Real JM; Carrión JA; Graupera I; Ginès P
    Med Clin (Barc); 2019 Aug; 153(4):169-177. PubMed ID: 31178295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Consensus document. Management of non-alcoholic fatty liver disease (NAFLD). Clinical practice guideline.
    Aller R; Fernández-Rodríguez C; Lo Iacono O; Bañares R; Abad J; Carrión JA; García-Monzón C; Caballería J; Berenguer M; Rodríguez-Perálvarez M; Miranda JL; Vilar-Gómez E; Crespo J; García-Cortés M; Reig M; Navarro JM; Gallego R; Genescà J; Arias-Loste MT; Pareja MJ; Albillos A; Muntané J; Jorquera F; Solà E; Hernández-Guerra M; Rojo MÁ; Salmerón J; Caballería L; Diago M; Molina E; Bataller R; Romero-Gómez M
    Gastroenterol Hepatol; 2018 May; 41(5):328-349. PubMed ID: 29631866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AGA Clinical Practice Update on Screening and Surveillance for Hepatocellular Carcinoma in Patients With Nonalcoholic Fatty Liver Disease: Expert Review.
    Loomba R; Lim JK; Patton H; El-Serag HB
    Gastroenterology; 2020 May; 158(6):1822-1830. PubMed ID: 32006545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.